Michael Luo CFA
Stock Analyst at CLSA
(3.90)
# 1,855
Out of 4,596 analysts
76
Total ratings
48.6%
Success rate
11.4%
Average return
Main Sectors:
Stocks Rated by Michael Luo CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Downgraded: Hold | $219 | $232.51 | -5.81% | 5 | Jul 20, 2026 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Buy | $58.90 → $52.10 | $37.08 | +40.51% | 8 | Oct 30, 2025 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Maintained: Buy | $137.10 → $138.60 | $160.00 | -13.38% | 13 | Oct 27, 2025 | |
| HKG: 6078 Hygeia Healthcare Holdings Co., Limited | Maintained: Buy | $17.30 → $17.00 | $9.90 | +71.72% | 6 | Aug 29, 2025 | |
| HKG: 1951 Jinxin Fertility Group Limited | Maintained: Buy | $3.80 → $3.50 | $2.20 | +59.45% | 3 | Aug 28, 2025 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Maintained: Buy | $74.30 → $110.20 | $108.80 | +1.29% | 7 | Aug 27, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $34.80 → $42.60 | $38.48 | +10.71% | 9 | Aug 25, 2025 | |
| HKG: 0867 China Medical System Holdings Limited | Maintained: Buy | $10.00 → $15.60 | $11.72 | +33.11% | 4 | Aug 20, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Maintained: Buy | $27.80 → $43.10 | $31.08 | +38.67% | 2 | Aug 20, 2025 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Maintained: Buy | $7.00 → $9.20 | $4.93 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,230 | ¥2,308 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,490 | ¥3,563 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63.00 → $42.00 | $28.98 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 702.00 → CHF 723.00 | CHF 562.20 | n/a | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,850 | ¥1,820 | n/a | 1 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9.80 → $11.00 | $22.64 | n/a | 3 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.50 | $1.17 | n/a | 1 | Apr 4, 2024 |
Charles River Laboratories International
Jul 20, 2026
Downgraded: Hold
Price Target: $219
Current: $232.51
Upside: -5.81%
Hangzhou Tigermed Consulting Co., Ltd
Oct 30, 2025
Maintained: Buy
Price Target: $58.90 → $52.10
Current: $37.08
Upside: +40.51%
WuXi AppTec Co., Ltd.
Oct 27, 2025
Maintained: Buy
Price Target: $137.10 → $138.60
Current: $160.00
Upside: -13.38%
Hygeia Healthcare Holdings Co., Limited
Aug 29, 2025
Maintained: Buy
Price Target: $17.30 → $17.00
Current: $9.90
Upside: +71.72%
Jinxin Fertility Group Limited
Aug 28, 2025
Maintained: Buy
Price Target: $3.80 → $3.50
Current: $2.20
Upside: +59.45%
Asymchem Laboratories (Tianjin) Co., Ltd.
Aug 27, 2025
Maintained: Buy
Price Target: $74.30 → $110.20
Current: $108.80
Upside: +1.29%
WuXi Biologics (Cayman) Inc.
Aug 25, 2025
Maintained: Buy
Price Target: $34.80 → $42.60
Current: $38.48
Upside: +10.71%
China Medical System Holdings Limited
Aug 20, 2025
Maintained: Buy
Price Target: $10.00 → $15.60
Current: $11.72
Upside: +33.11%
Hansoh Pharmaceutical Group Company Limited
Aug 20, 2025
Maintained: Buy
Price Target: $27.80 → $43.10
Current: $31.08
Upside: +38.67%
Sino Biopharmaceutical Limited
Jul 21, 2025
Maintained: Buy
Price Target: $7.00 → $9.20
Current: $4.93
Upside: n/a
May 20, 2025
Maintained: Buy
Price Target: ¥3,230
Current: ¥2,308
Upside: n/a
May 20, 2025
Maintained: Buy
Price Target: ¥2,490
Current: ¥3,563
Upside: n/a
Apr 8, 2025
Maintained: Buy
Price Target: $63.00 → $42.00
Current: $28.98
Upside: n/a
Dec 12, 2024
Maintained: Buy
Price Target: CHF 702.00 → CHF 723.00
Current: CHF 562.20
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: ¥2,850
Current: ¥1,820
Upside: n/a
Apr 10, 2024
Upgraded: Buy
Price Target: $9.80 → $11.00
Current: $22.64
Upside: n/a
Apr 4, 2024
Maintained: Sell
Price Target: $1.50
Current: $1.17
Upside: n/a